Synthesis and antimicrobial activity of functional analogues of fluconazole

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 2, 2010, Pages 132-133

  Toraskar, P Mrunmayee ^a   Kadam, Vilasrao J ^a   Kulkarni, Vithal M ^b  

^a Department of Pharmaceutical Chemistry ^*  (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

1,2,4 triazole; CYP450; Fluconazole

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 2 (2,4 DIFLUOROPHENYL) 1 (PYRAZIN 2 YLAMINO) 3 (1H 1,2,4 TRIAZOL 1 YL)PROPAN 2 OL; 2 (2,4 DIFLUOROPHENYL) 1 [(3 PYRIDIN 3 YL 5 SULFANYL 4H 1,2,4 TRIAZOL 4 YL)AMINO] 3 (1H 1,2,4 TRIAZOL 1 YL)PROPAN 2 OL; 2 (2,4 DIFLUOROPHENYL) 1 [[3 (2 FURYL) 5 MERCAPTO 4H 1,2,4 TRIAZOL 4 YL]AMINO] 3 (1H 1,2,4 TRIAZOL 1 YL)PROPAN 2 OL; 2 (2,4 DIFLUOROPHENYL) 1 [[3 (BENZTRIAZOLYLMETHYL) 5 MERCAPTO 4H 1,2,4 TRIAZOL 4 YL]AMINO] 3 (1H 1,2,4 TRIAZOL 1 YL)PROPAN 2 OL; 2 (2,4 DIFLUOROPHENYL) 1 [[3 MERCAPTO 5 (4 METHYLPHENYL) 4H 1,2,4 TRIAZOL 4 YL]AMINO] 3 (1H 1,2,4 TRIAZOL 1 YL)PROPAN 2 OL; 4 [4 [[2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL]AMINO] 5 SULFANYL 4H 1,2,4 TRIAZOL 3 YL]PHENOL; FLUCONAZOLE; FLUCONAZOLE DERIVATIVE; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 77953397108     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Eggimen, P; Garbino J; Pittel D; Lancet Infect Dis.2003, 3, 772-779
2. Passannanti A: Diana P., Barraja P., Mingoia F., Lauria A: Torlorano, A.M; Caspani, L; Rigoni, A.L; Biraghi, E; Sicignano, A, Viviani, M.A.J. Hosp Infect. 2004,57,8
3. Patterson, T.F; Lancet 2005,366,1013.
4. Sheehan, D.J; Hitchcock, C.A; Sibley, C.M. Clin. Microbiol. Rev. 1999,12, 40.
5. Vanden Bossche, II. In Curr. Top. Med. Mycol, McGuinnis, M.R,E; Springer Berlin 1985, Vol. I., 313
6. Aoyama, Y; Yoshida, Y; Sato, R.J. Biol. Chem. 1984, 250.1661
7. Trzaskos, J.M; Bo wen, W.D; Shahee, A; Fischer, R.T.: Gaylor J.L.J Biol. Chem. 1984,259, 13402
8. J.P. Latge, Clin Microbiol. Rew. 12(1999), 310
9. J.N Steenbergen. A. Casadevall, J. Clin. Microbiol. 38(2000) 1974
10. Behringer H.; Fischer H.J; Berichte. 1962,96,2546.
11. Hosur M.S; Talwar R., Ind. J.Pharm Sci. 1993, 55,86.
12. Ilkay K, Sevim R., Farmaco. 2004, 55 (II), 893. Cirrincione G., Heterocycles, 1998,48,1229.
13. Jilino M., Stevens F.G.; J. Chem. Soc. Perkin Transl. 1998, 1677
14. Holla S.B, Veerendra B, Shavananda M.K. Eur J.Med.Chem. 2003, 38, 759.
15. K. S. Dhaka, J. Mohan, V.K. Chadha, H.K. Pujari, Indian J.Chem. 2(1974)288
16. J. R. Reid, N.D. Heindel, J.Heterocycl.Chem.13 (1976) 925-926
17. R.G. Karki, V.M. Gokhale, Prashant S. Kharkar and V.M. Kulkarni.; Indian J.Chem.42B, Feb 2003, 372-381.
18. Barry A.L., The Antimicrobial Test: Principle and Practice, Lea and Febiger, Philadelphia, 1976,180.
19. Glide, Version 5.0, Schrodinger, L. L C, and New York, USA.